GMAB - Pfizer Genmab cancer therapy under FDA priority review for full approval
2024-01-09 07:13:52 ET
More on Genmab, Pfizer, etc.
- Pfizer Inc. (PFE) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
- Pfizer: 50% Down From The Highs, Generous Dividend, And Robust Balance Sheet
- Pfizer: Paying Too Much To Boost Revenues
- Pfizer wins EU nod for prostate cancer combination therapy
- Florida wins FDA nod for mass drug imports from Canada (update)
For further details see:
Pfizer, Genmab cancer therapy under FDA priority review for full approval